Showing results (1-10 of 299) with videos related to
Sort By:
Pageof 30
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 22, 2007
Combinatorial RNAi: a winning strategy for the race against evolving targets?Dirk Grimm, Mark A KayThe Journal of Clinical Investigation|December 7, 2007
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?Dirk Grimm, Mark A KayHematology. American Society of Hematology. Education Program|November 21, 2007
RNAi and gene therapy: a mutual attractionDirk Grimm, Mark A KayMethods in Enzymology|January 13, 2005
Adeno-associated virus vectors for short hairpin RNA expressionDirk Grimm, Kusum Pandey, Mark A KayMolecular Therapy : the Journal of the American Society of Gene Therapy|June 6, 2003
Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6Dirk Grimm, Mark A Kay, Juergen A KleinschmidtHuman Gene Therapy|May 27, 2005
Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivoEfren Riu, Dirk Grimm, Zan Huang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2008
Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeuticJeffery C Giering, Dirk Grimm, Theresa A Storm, et al.Journal of Virology|December 15, 2005
Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotypeDirk Grimm, Kusum Pandey, Hiroyuki Nakai, et al.Nucleic Acids Research|January 3, 2012
Expression determinants of mammalian argonaute proteins in mediating gene silencingPaul N Valdmanis, Shuo Gu, Nina Schüermann, et al.Journal of Virology|September 16, 2006
The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9Bassel Akache, Dirk Grimm, Kusum Pandey, et al.Pageof 30